Skip to main content

Leukemia With IKZF₁ Deletion Benefits From Prolonged Maintenance Therapy

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

MONDAY, July 31, 2023 -- For children with acute lymphoblastic leukemia (ALL), cases with IKZF₁ deletion (IKZF₁del) benefit from prolonged maintenance therapy, according to a study published online July 17 in the Journal of Clinical Oncology.

Noting that IKZF₁del ALL showed poor response to the ALL10 protocol in children in the largest minimal residual disease-defined medium-risk group, accounting for a high number of overall relapses, Rob Pieters, M.D., Ph.D., from the Princess Maxima Center for Pediatric Oncology in Utrecht, Netherlands, and colleagues compared results for the ALL11 protocol, which prolonged therapy for IKZF₁del from two to three years, with the ALL10 protocol. A total of 819 patients with ALL were enrolled in ALL11 and stratified as in ALL10.

The researchers found that in ALL11, the five-year overall survival, event-free survival (EFS), cumulative risk for relapse (CIR), and death in complete remission were 94.2, 89.0, 8.2, and 2.3 percent, respectively. Five-year CIR improved to 10.8 percent from 23.4 percent, and EFS improved to 87.1 percent from 72.3 percent with prolonged maintenance. In a landmark analysis at two years from diagnosis, there was a 2.9-fold reduction of CIR (25.6 to 8.8 percent) and improvement in EFS (74.4 to 91.2 percent). Reduced therapy did not negate the five-year outcomes for ETV6::RUNX₁, Down syndrome, or poor prednisone responders.

"Children with IKZF₁del ALL seem to benefit from a third year of therapy, suggesting to change therapy accordingly for this class of patients," the authors write.

Several authors disclosed ties to the pharmaceutical industry.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted July 2023

Read this next

First Responders With More Debris Exposure Have Higher Risk of Early Dementia

FRIDAY, June 14, 2024 -- More severe exposure to dust or debris among World Trade Center (WTC) responders is significantly associated with a higher risk of dementia at <65...

1990 to 2019 Saw Increase in Life Expectancy in Seniors With T1DM

FRIDAY, June 14, 2024 -- From 1990 to 2019, there was an increase in life expectancy in older people with type 1 diabetes mellitus (T1DM), according to a study published online...

Second Tumors Are Rare After Chimeric Antigen Receptor T-Cell Therapy

FRIDAY, June 14, 2024 -- Second tumors are rarely seen after chimeric antigen receptor (CAR) T-cell therapy, according to a study published in the June 13 issue of the New England...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.